Skip to main content

Table 1 Verification of LOD with clinical samples

From: Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples

 

MPS

Idylla™ KRAS Mutation Test

16S106

G12C (10% TTC: 31%VAF)

G12C

16K11

G12C (5-10% TTC: 33% VAF)

G12C

16O1048

G12V (10% TTC; 3% VAF)

G12V

16EM117

G12D (10% TTC, 18%VAF)

G12D

  1. TTC tumor tissue content, VAF variant allele frequency